Osaka, Japan

Takeshi Noshi

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 7.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Takeshi Noshi in Influenza Prevention

Introduction

Takeshi Noshi is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medicine, particularly in the prevention of influenza virus transmission. With a total of 3 patents, his work focuses on innovative methods to combat viral infections.

Latest Patents

One of his latest patents is a compound and method for the prevention of transmission of the influenza virus. This invention relates to a method that involves administering an effective amount of a compound to a patient infected with the influenza virus, referred to as the 'index patient'. The compound is designed to reduce the infectivity of the influenza virus in the index patient, thereby minimizing the risk of triggering an influenza epidemic or pandemic. The method requires that the compound be administered to at least 10% of all influenza-infected individuals within a city's or country's population.

Career Highlights

Throughout his career, Takeshi Noshi has worked with prominent companies such as Shionogi & Company Limited and Hoffmann-La Roche Inc. His experience in these organizations has contributed to his expertise in developing effective antiviral compounds.

Collaborations

Takeshi has collaborated with notable coworkers, including Takao Shishido and Takahiro Noda. These partnerships have likely enhanced his research and development efforts in the field of influenza prevention.

Conclusion

Takeshi Noshi's innovative work in the prevention of influenza virus transmission showcases his dedication to improving public health. His patents reflect a commitment to finding effective solutions to combat viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…